Advertisement
Screener

MeiraGTx Holdings plc (MGTX) Graph

MGTX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $321.43M; Research and development $57.83M; Operating expenses $77.01M; Income tax $2.36M.
  • 2026-03-31: Revenue $293.00K; Research and development $31.98M; Operating expenses $41.11M; Income tax $0.00.
  • 2025-12-31: Revenue $75.36M*; Research and development $30.81M*; Operating expenses $48.89M*; Income tax $0.00*.
  • 2025-09-30: Revenue $410.00K; Research and development $32.53M; Operating expenses $46.46M; Income tax (m).

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MGTX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Service$11.88MRelated PartyLicense Revenue$204.64MRelated PartyService Revenue$104.91MRevenue$321.43MOperating expenses$77.01MOperating income$244.42MResearch & development$57.83MIncome tax$2.36M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$321.43M$57.83M$77.01M$2.36M$160.72M
2026-03-31$293.00K$31.98M$41.11M$0.00-$46.31M
2025-12-31$75.36M*$30.81M*$48.89M*$0.00*$15.09M*
2025-09-30$410.00K$32.53M$46.46M(m)-$50.51M
2025-06-30$3.69M$33.49M$48.48M(m)-$38.80M
2025-03-31$1.93M$32.78M$43.52M$0.00-$39.98M
2024-09-30$10.91M$26.24M$50.95M$0.00-$39.33M
2024-06-30$282.00K$34.93M$46.19M$0.00-$48.62M
2024-03-31$697.00K$34.32M$47.47M$0.00-$20.44M
2023-09-30$5.10M$27.86M$37.87M$0.00-$44.30M
2023-06-30$3.54M$19.94M$32.33M$0.00-$29.58M
2023-03-31$3.33M$22.32M$35.09M$0.00-$30.36M
2022-09-30$4.82M$16.86M$27.62M$0.00-$37.28M
2022-06-30$10.76M$24.00M$34.52M$0.00-$33.97M
2022-03-31$5.63M$23.10M$34.37M$0.00-$31.05M
2021-09-30$6.95M$21.61M$29.50M$0.00-$25.95M
2021-06-30$5.12M$15.19M$25.60M$0.00-$20.09M
2021-03-31$4.59M$16.71M$26.63M$0.00-$23.62M
2020-09-30$5.09M$4.63M$13.52M$0.00-$6.43M
2020-06-30$2.47M$16.20M$27.70M$0.00-$25.42M
2020-03-31$4.21M$8.08M$19.89M$0.00-$15.68M
2019-09-30$3.58M$4.61M$14.49M-$338.67K-$10.46M
2019-06-30$1.98M$9.77M$23.21M-$91.39K-$20.82M
2019-03-31$784.96K$12.98M$21.48M$0.00-$17.98M
2018-09-30(m)$8.11M$14.74M$0.00-$15.42M
2018-06-30(m)$7.79M$25.17M$0.00-$29.98M
2018-03-31(m)$6.93M$18.05M$0.00-$16.40M
2017-09-30(m)$6.39M$8.76M$0.00-$8.44M
2017-06-30(m)$5.36M$7.59M$0.00-$7.18M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$321.73M$89.82M$118.12M$2.36M$114.41M
2025-06-30$5.62M$66.28M$92.01M$0.00-$78.78M
2024-06-30$979.00K$69.26M$93.66M$0.00-$69.06M
2023-06-30$6.87M$42.26M$67.42M$0.00-$59.95M
2022-06-30$16.39M$47.10M$68.88M$0.00-$65.02M
2021-06-30$9.71M$31.90M$52.23M$0.00-$43.70M
2020-06-30$6.68M$24.29M$47.59M$0.00-$41.10M
2019-06-30$2.77M$22.75M$44.68M-$91.39K-$38.80M
2018-06-30(m)$14.72M$43.22M$0.00-$46.38M
2017-06-30(m)$10.19M$14.56M$0.00-$14.00M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$6.03M$98.81M$138.47M$0.00-$129.29M
2024-09-30$11.89M$95.50M$144.61M$0.00-$108.39M
2023-09-30$11.98M$70.11M$105.28M$0.00-$104.24M
2022-09-30$21.21M$63.96M$96.51M$0.00-$102.30M
2021-09-30$16.66M$53.51M$81.73M$0.00-$69.65M
2020-09-30$11.78M$28.91M$61.11M$0.00-$47.53M
2019-09-30$6.35M$27.36M$59.17M-$430.06K-$49.27M
2018-09-30(m)$22.83M$57.96M$0.00-$61.81M
2017-09-30(m)$16.58M$23.32M$0.00-$22.44M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$81.39M$129.62M$187.36M$0.00-$114.20M
2024-12-31$33.28M$119.48M$197.49M$0.00-$147.79M
2023-12-31$14.02M$103.78M$151.08M$0.00-$84.03M
2022-12-31$15.92M$85.72M$132.28M(m)-$129.62M
2021-12-31$37.70M$66.69M$110.46M$0.00-$79.56M
2020-12-31$15.56M$33.91M$78.12M$0.00-$57.99M
2019-12-31$13.29M$24.88M$71.56M$0.00-$54.75M
2018-12-31(m)$33.62M$78.10M-$474.39K-$82.87M
2017-12-31(m)$22.36M$31.68M$0.00-$31.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10